Drugs / HUNS001-01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06752720 | Dec 2024 → Dec 2025 overdue | ischemic stroke | Hokkaido University Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HUNS001-01 | “autologous mesenchymal stem cell (HUNS001-01) transplantation therapy can provide neurological recovery in patients with chronic stage of stroke” NCT06752720 ↗ |
| Modality | Cell therapy | “autologous mesenchymal stem cell (HUNS001-01) transplantation therapy” NCT06752720 ↗ |
| Route | Other | “will be injected into the brain” NCT06752720 ↗ |